|
Caraco Pharmaceutical Laboratories, Ltd. - Comparative Business Analysis Snapshot
Business Description
Caraco Pharmaceutical Laboratories, Ltd.. The Company's principal activity is the developing, manufacturing and marketing generic and private-label pharmaceuticals. A generic drug is a pharmaceutical product, which is the chemical and therapeutic equivalent of a brand name drug as to which the patent and/or market exclusivity has expired. The Company's present product portfolio consists of 52 prescription products in 114 strengths in various package sizes. The products relate to a variety of therapeutic segments including the central nervous system, cardiology, pain management and diabetes. The customers include wholesalers, buying groups, managed care organizations, chain retail pharmacies, independent retail pharmacies and hospitals. The Company operates throughout the United States.
Competitor Analysis
This analysis compares Caraco Pharmaceutical Laboratories, Ltd. with three other companies in closely related industry sectors.
The full Comparative Business Report is available to Subscribers or may be purchased individually. The full report generally includes the following sections:
- Sales Analysis: Recent Sales, Sales Growth, Sales per Employee
- Recent Stock Performance
- Company Valuation Ratios: Price/Earnings, Price/Book Value
- Price/Sales and 52 Week Price change
- Dividend Analysis
- Profitability Analysis: Gross Profit Margin, EBITDA Margin
- Earnings Before Extraordinary Items
- Inventory Analysis
- Research and Development Expenses
- Financial Position: Long Term Debt/Equity, Days Accounts Receivable, Days Inventory
- R&D Expenses/Sales
Not the Report you are looking for? Click here for more browsing options.
|
